Make your mark for patients.

We're here because we want to build the future and transform patients' lives for the better. At UCB, our people are our experiences and achievements, our passion and drive. That's why we're looking for talented individuals with diverse backgrounds and experiences - not just the best and brightest, but those who care about making a meaningful difference in the lives of patients. We promote an environment of diversity, openness, and respect where people can make valuable contributions.

An exciting journey lies ahead. Will you join us in pushing the boundaries of what's possible?

UCB's Boston R&D Hub is developing a platform to evaluate new druggable targets within the area of nucleotide repeat disorders, linking genetics to molecular pathways to organ dysfunction.

We are looking to add a Scientist I or II to our team who will have responsibility for investigating causal pathobiology within this area with the goal of identifying druggable molecular targets. The lab-based scientist will also have responsibility for developing and executing assays for discovery of new therapeutics. The goal is to build confidence in novel targets to facilitate further investment.

Major Accountabilities / Responsibilities:

• Develop, troubleshoot, and validate new assays, including translatable cell-based models
• Have accountability for achieving drug project milestones and delivering on objectives through effective internal and external collaboration across different geographies
• Drive scientific excellence and technology developments to maximize both current and future impact on programs and projects
• Provide strong scientific thinking, develop hypotheses, and drive scientific learnings on projects

Minimum Experience / Skills Required:

• PhD with 0-4 years of applicable research experience with excellent scientific track record
• Direct experience with the design, development, optimization, and prosecution of experiments for new target ID/validation
• Direct hands-on experience with advanced cell and molecular biology techniques and experience with culturing a wide variety of human cell lines
• Experience with applying cellular and biochemical techniques for target validation, drug discovery screening and evaluating the mechanism of action of novel molecular entities
• Experience with the analysis and statistics relevant to in vitro screens
• Excellent communicator, with good presentation and organizational skills

Preferred Experience / Skills:

• Experience with small molecules/ligands/therapeutics is preferred
• Working knowledge or experience with CRISPR screening approaches is a plus
• Knowledge of targeted protein degradation is a plus
• Neuroscience and/or immunology background is a plus
• Preference for candidates with direct industry experience
• Independent scientist who can drive with minimal supervision but also to thrive in a multidisciplinary team environment

About us:

At UCB, we come together every day to work, laser-focused, on a simple question: How will this create value for people living with severe diseases? By putting patients at the heart of everything we do, our approach - from discovery to development to delivery - is continuously transformed and designed around patient needs and their journey.

With a team of approximately 7,600 employees and worldwide operations in more than 40 countries, we are a global biopharmaceutical company investing more than a quarter of our revenue in cutting-edge scientific research. We are focused on addressing chronic, neurological, immunological, and bone diseases. We are looking for people with passion and empathy who develop a real understanding of patient's needs and can deliver thoughtful solutions to decisionmakers across the heath care ecosystem.

Curious to know more? Please visit our website .

The Company is an equal opportunity employer. We evaluate qualified applicants without regard to race, color, national origin, religion, gender, age, marital status, disability, veteran status, sexual orientation, gender identity, or any other characteristic protected by law.

Where permitted, applicants for employment in the United States must either have received or been willing to receive a full COVID-19 vaccination by the date of hire; or, alternatively, agree to be subject to weekly COVID-19 testing, subject to religious and medical exemptions and in accordance with applicable law.